晚期钆增强在主动脉瓣狭窄中的预后作用:系统评价与荟萃分析
该系统评价与荟萃分析纳入6项研究共1151例主动脉瓣狭窄患者,49.1%存在晚期钆增强(LGE)。汇总分析显示LGE是全因死亡的强单变量预测因子(未校正OR 2.56,95%CI 1.83-3.57,I²=0%),校正基线特征后仍独立相关(校正HR 2.50,95%CI 1.64-3.83,I²=0%)。
要点
- 主动脉瓣狭窄患者中LGE阳性率49.1%,LGE是全因死亡的强预测因子(未校正OR 2.56)。
- 校正基线特征后LGE仍独立与死亡相关(校正HR 2.50,95%CI 1.64-3.83)。
- LGE-CMR上的纤维化可能作为主动脉瓣狭窄风险分层的新标志物。
核心结论
- LGE-CMR上的纤维化是主动脉瓣狭窄患者全因死亡的强预测因子,可能作为风险分层的新标志物;未来研究应探索LGE-CMR是否可用于优化主动脉瓣狭窄相关干预的时机。
研究设计与样本
- 系统评价与荟萃分析,检索电子数据库纳入6项研究共1151例主动脉瓣狭窄患者,采用随机效应模型,异质性用I²统计量评估。
诊断标准与关键数值
- LGE在主动脉瓣狭窄患者中阳性率为49.1%;LGE预测全因死亡的未校正OR为2.56(95%CI 1.83-3.57,I²=0%);4项研究报告校正HR,汇总校正HR为2.50(95%CI 1.64-3.83,I²=0%)。
局限性
- 未来研究应探索LGE-CMR是否也可用于优化主动脉瓣狭窄相关干预的时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this systematic review was to explore the prognostic value of late gadolinium enhancement (LGE) in patients with aortic stenosis (AS).
BACKGROUND: Myocardial fibrosis is a common feature of many cardiac diseases. Cardiac magnetic resonance (CMR) has the ability to noninvasively detect regional fibrosis by using the LGE technique. Several studies have explored whether LGE is associated with adverse outcome in patients with AS.
METHODS: Electronic databases were searched to identify studies investigating the ability of LGE to predict all-cause mortality in patients with AS. A random effects model meta-analysis was conducted. Heterogeneity was assessed with the I2 statistic.
RESULTS: Six studies comprising 1,151 patients met our inclusion criteria. LGE was present in 49.1% of patients with AS. In the pooled analysis, LGE was found to be a strong univariate predictor of all-cause mortality (pooled unadjusted odds ratio: 2.56; 95% confidence interval: 1.83 to 3.57; I2 = 0%). Four of the included studies reported adjusted hazard ratios for mortality. LGE was independently associated with mortality, even after adjusting for baseline characteristics (pooled adjusted hazard ratio: 2.50; 95% confidence interval: 1.64 to 3.83; I2 = 0%).
CONCLUSIONS: Fibrosis on LGE-CMR is a powerful predictor of all-cause mortality in patients with AS and may serve as a novel marker for risk stratification. Future studies should explore whether LGE-CMR can also be used to optimize timing of AS-related interventions.
引用
- Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, et al. The Prognostic Role of Late Gadolinium Enhancement in Aortic Stenosis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2019. PMID: 31326491. doi:10.1016/j.jcmg.2019.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。